Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 5261-5270 of 13615

Page
per page
  1. SAR191801
    B5840 SAR191801
    Summary: hPGDS inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.6 mg/mL
  2. Deferoxamine mesylate
    B6068 Deferoxamine mesylate
     16 Citation
    Summary: iron-chelating agent
      ≥65.7 mg/mL
  3. Lincomycin HCl
    B1962 Lincomycin HCl
    Summary: lincosamide antibiotic
      insoluble in EtOH; ≥35.3 mg/mL
  4. 6-CFDA
    A4679 6-CFDA
    Summary: A fluorescent probe for cell labeling and cell viability detection
      ≥6.9 mg/mL
  5. LY 266097 hydrochloride
    B7583 LY 266097 hydrochloride
    Summary: 5-HT2B receptor antagonist
      Soluble in DMSO
  6. Ac-D-Ala-OH
    BA9517 Ac-D-Ala-OH
    Summary: An alanine derivative.
  7. Pelcitoclax
    BA2822 Pelcitoclax
    Summary: Pelcitoclax (APG-1252) is a potent inhibitor.
  8. KT-531
    BA4172 KT-531
    Summary: KT-531 is a potent and selective inhibitor.
  9. Iron Dextran
    C8958 Iron Dextran
    Summary: An iron-dextran complex used for the treatment of iron-deficiency anemia
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  10. AHU-377 hemicalcium salt
    B3267 AHU-377 hemicalcium salt
    Summary: Potent neprilysin inhibitor
      ≥17.9 mg/mL

Items 5261-5270 of 13615

Page
per page